ELEV Chart
- 52-Week Range: $1.26 - $16.11
- Market Capitalization: $32.56M
- Short Percentage: 0%
- Target Price: $12.67
- Shares Outstanding: 23.25M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ELEV released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Elevation Oncology Appoints David Dornan, Ph.D., as Chief Scientific OfficerPRNewsWire | March 14th
- Elevation Oncology Reports Fourth Quarter and Full Year 2021 Financial ResultsPRNewsWire | March 3rd
- Elevation Oncology to Participate at Upcoming Virtual Investor ConferencesPRNewsWire | March 1st
- Elevation Oncology Highlights 2021 Achievements and Outlines Expected 2022 MilestonesPRNewsWire | January 10th
- Elevation Oncology to Present at the H.C. Wainwright BIOCONNECT Virtual ConferencePRNewsWire | January 6th
- Elevation Oncology to Present at the Piper Sandler 33rd Annual Virtual Healthcare ConferencePRNewsWire | November 18th
- Elevation Oncology to Present at the H.C. Wainwright 23rd Annual Global Investment ConferencePRNewsWire | September 7th
Company Info
Website: https://elevationoncology.com
Address: 888 Seventh Avenue, New York, NY, United States, 10106
Sector: Other
Industry: Other
Full time employees: 39
Address: 888 Seventh Avenue, New York, NY, United States, 10106
Sector: Other
Industry: Other
Full time employees: 39
$ELEV buying this dip
$ELEV has just been halted from trading due to volatility.
$ELEV has just been halted from trading due to volatility.
$ELEV has just been halted from trading due to volatility.
$ELEV has just been halted from trading due to volatility.
$ELEV see you on the moon
$ELEV Not Selling
Hodling for thousands!
$ELEV Let it go...
$ELEV whats the news????
$ELEV has just been halted from trading due to volatility.